In Focus: Advertising, Labeling & Promotion

| 01 November 2009

A two-day FDA public meeting on social media… Issuance of two FDA guidance documents relating to Good Reprint Practices and presentation of risk information in prescription drug and medical device promotion… A legal challenge to FDA's policies on off-label promotion… An increase in FDA enforcement letters relating to product promotion, with more likely to come… Yes, advertising and promotion remains a hot regulatory topic, with more activity to come.


© 2022 Regulatory Affairs Professionals Society.

Discover more of what matters to you

No taxonomy